Press Releases

Press Releases

July 20, 2023
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif. , July 20, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that on July 19, 2023 , the Company granted its recently appointed Senior Vice President, Chief Medical
Additional Formats
June 1, 2023
CytomX Therapeutics to Present at the Jefferies Healthcare Conference
SOUTH SAN FRANCISCO, Calif. , June 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy , D.Phil ., chief executive officer and chairman, will present at the Jefferies
Additional Formats
Displaying 1 - 10 of 18